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Abstract
Background: The annual burden of disease caused indoor air pollution, including polluted outdoor air used to
ventilate indoor spaces, is estimated to correspond to a loss of over 2 million healthy life years in the European
Union (EU). Based on measurements of the European Environment Agency (EEA), approximately 90 % of EU citizens
live in areas where the World Health Organization (WHO) guidelines for air quality of particulate matter sized <
2.5 mm (PM2.5) are not met. Since sources of pollution reside in both indoor and outdoor air, selecting the most
appropriate ventilation strategy is not a simple and straightforward task.
Methods: A framework for developing European health-based ventilation guidelines was created in 2010–2013 in
the EU-funded HEALTHVENT project. As a part of the project, the potential efficiency of control policies to health
effects caused by residential indoor exposures of fine particulate matter (PM2.5), outdoor bioaerosols, volatile
organic compounds (VOC), carbon oxide (CO) radon and dampness was estimated. The analysis was based on
scenario comparison, using an outdoor-indoor mass-balance model and varying the ventilation rates. Health effects
were estimated with burden of diseases (BoD) calculations taking into account asthma, cardiovascular (CV) diseases,
acute toxication, respiratory infections, lung cancer and chronic obstructive pulmonary disease (COPD).
Results: The quantitative comparison of three main policy approaches, (i) optimising ventilation rates only; (ii)
filtration of outdoor air; and (iii) indoor source control, showed that all three approaches are able to provide
substantial reductions in the health risks, varying from approximately 20 % to 44 %, corresponding to 400 000 and
900 000 saved healthy life years in EU-26. PM2.5 caused majority of the health effects in all included countries, but
the importance of the other pollutants varied by country.
Conclusions: The present modelling shows, that combination of controlling the indoor air sources and selecting
appropriate ventilation rate was the most effective to reduce health risks. If indoor sources cannot be removed or
their emissions cannot be limited to an accepted level, ventilation needs to be increased to remove remaining
pollutants. In these cases filtration of outdoor air may be needed to prevent increase of health risks.
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Background
In the period 2006–2010, focus on indoor air quality has
been raised by WHO, who has issued specific guidelines
addressing air exposure in indoor spaces [1, 2]. Over the
last previous two decades WHO had coordinated sys-
tematic reviews of scientific evidence and set Air Quality
Guidelines [3, 4], although not specific for indoor air.
Requirements for indoor air quality (IAQ) in buildings
is prescribed by existing standards for ventilation, but
are often poorly related on health. At present, many ven-
tilation standards (e.g. EN15251 [5]) define ventilation
requirements in non-industrial buildings to meet com-
fort requirements of occupants, specified by the percent-
age of dissatisfied persons with indoor air quality and/or
by the intensity of odour. While comfort is an important
parameter, it does not fully reflect more serious health
impacts like asthma, allergies, chronic obstructive pul-
monary disease, cardiovascular diseases, lung cancer and
acute toxication that are caused by exposures to pollut-
ants present in indoor air. There are no European guide-
lines to recommend how the buildings should be
ventilated to reduce the health risks of the occupants’
exposed to indoor air pollutants.
Direct scientific evidence on the relationship between
ventilation and health is quite limited. In reviews by
Wargocki et al. (2002) [6] and by Seppänen et al. (2004)
[7], concentrating on office-type working environment
and residential buildings, ventilation was considered to
significant impact or association with comfort (perceived
air quality, PAQ) and health (including sick building syn-
drome (SBS) symptoms, inflammation, infections, asthma,
allergy, and short-term sick leaves), and productivity (per-
formance of office work).
Li et al. (2007) [8] performed a systematic review of
the role of the built environment in the transmission of
airborne infectious agents. They concluded that there is
strong evidence that suggests the association between
ventilation, air movements in buildings and the trans-
mission/spread of infectious diseases such as measles,
tuberculosis, chickenpox, influenza, smallpox and severe
acute respiratory syndrome (SARS).
Sundell et al. (2011) [9] identified 27 papers published
in peer reviewed journals providing sufficient information
on both ventilation rates and health effects in non-
industrial buildings. Multiple health endpoints showed
similar relationships with ventilation rate and were bio-
logically plausible, although the literature did not provide
clear evidence on particular agents. Higher ventilation
rates in offices, up to about 25 l/s per person, were shown
in the reviewed literature to be associated with reduced
prevalence of SBS symptoms. Limited data suggested that
inflammation, respiratory infections, asthma symptoms
and short-term sick leave increase with lower ventilation
rates. Home ventilation rates above 0.5 air changes per
hour (h−1) were shown in the reviewed papers to be asso-
ciated with reduced risk of allergic manifestations among
children in a Nordic climate.
The role of outdoor air quality on indoor exposures
was not addressed in any of the studies included in the
above mentioned reviews, even though 90 % of EU citi-
zens live in areas where the WHO guidelines for air qual-
ity for PM2.5 is not met [10]. Furthermore, the existence of
indoor air sources was not systematically analysed or ex-
posure levels quantified or considered when associating
ventilation and health. Therefore, there is limited support
from these previous studies on determining the best com-
bination of source control and ventilation levels.
This work aims to summarize the current understand-
ing of the sources of health risks in indoor environments
and their relationship to ventilation requirements. Spe-
cific objectives of the study are: i) summarize the sources
and magnitudes of health risks indoors, ii) provide a
quantitative framework for estimation of long-term
health effects caused by poor indoor air quality in resi-
dential buildings, and iii) quantify the burden of disease
for each indoor exposure agent and evaluate efficiency
of exposure reduction measures for EU-26 countries. In
addition, the results are intended for development of na-
tional and international guidelines and standards, and
can also be used as background information when ana-
lysing indoor air quality related issues in buildings.
Methods
Exposures
Ventilation plays a dual role in formation of indoor pol-
lutant concentrations: on one hand it removes indoor
generated pollutants from indoor spaces by ventilating
the space with outdoor air, on the other hand, ventila-
tion introduces outdoor air pollutants indoors [11, 12].
It has been shown that efficient filtering of intake air does
not necessarily reduce penetration of outdoor air pollut-
ants as much as could be expected based on the filtration
efficiency as substantial fraction of the outdoor air enters
indoors through windows, doors, ventilation ducts, and
cracks and leaks in the building envelope [13].
When defining prevailing indoor air concentrations, a
mass-balance model is needed to address the counter-
acting roles of indoor and outdoor air sources. A com-
monly used approach based on Dockery and Spengler
[14] and adopted in Hänninen et al. [11], [15] is as
follows:
Ci ¼ Paaþ k
Ca þ GV aþ kð Þ−
ΔCi
Δt aþ kð Þ ð1Þ
where Ci is the total indoor concentration (μg m
−3) of
the pollutant in question, Ca is the concentration in the
intake air, P is the probability of the pollutant remaining
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suspended after penetrating through the building enve-
lope, α is air exchange rate (h−1), k is the deposition rate
of the pollutant indoors (h−1), G is the indoor generation
level (μg h−1), V is the volume of the indoor space and
Δt is change in temperature of the indoor space during
sampling period (h). The third term covering the transi-
ent impacts of changing concentration can be consid-
ered zero when assuming steady-state for the sake of
long-term average exposures.
Since the aim of this study is to estimate how changes in
ventilation affect exposures in residential indoor environ-
ments, the probability distributions of national ventilation
rates in residential building stock in year 2010 had to be es-
timated. Surprisingly limited data of measured ventilation
rates are available for residences in European countries
[16]. As a result, available measured data was reviewed
and a regression model was developed combining the
climatological and economical differences of European
countries with ventilation rates. Further modelling with
a Bayesian subjective probability approach was used for
generation of lognormal probability distributions for
ventilation rates in each EU-26 country (Table 1, list of
countries and ventilation rate distributions, method de-
scribed in detailed elsewhere [17]).
Risk model
A large number of indoor air pollutants have been associ-
ated with health responses, but some of those either play a
small role for public health, or pose challenges for the ex-
posure assessment or quantification of the burden of dis-
ease. Health determinants of housing in general are
discussed in WHO 2011 [18], safe levels of specific chemi-
cals indoors in WHO 2010 [2] and guidelines for exposure
to dampness and mould specifically in WHO 2009 [1].
Exposures to environmental pollutants are associated
with increased mortality and morbidity. Some of the
widely used risk assessment methods estimate these sep-
arately as numbers of cases. The results from such
incidence-based models are not comparable over differ-
ent types of health endpoints and to improve compar-
ability of impacts on various types of diseases and
including mortality, disability adjusted life years (DALY)
has been proposed as a common metric [19]. The fol-
lowing model and data used in this study and more de-
tails of calculations are presented in a technical report
published earlier [20].
The burden of disease methodology makes the years
of life lost (YLL) due to premature mortality and years
lived with a disability (YLD) comparable and is summing
them up as disability adjusted life years (DALY)
DALY ¼ YLLþ YLD ð2Þ
The disabilities caused by various types of diseases are
calculated accounting for the duration of the disease (L)
and scaled using a disease specific disability weight (DW)
and number of cases (N):
YLD ¼ DW  L N ð3Þ
The current enhancement of the health impact assess-
ment with the above described mass-balance approach, to
account for varying ventilation, is built on the previous
achievements of EnVIE [21] and IAIAQ projects [22] and
the corresponding models for environmental burden of
disease caused by indoor air quality. These models were
based on pollutant specific attributable fraction (by expert
judgements) of disease caused by indoor exposure and
European level burden of disease (BoD) data. National
Table 1 Estimated ventilation rate distributions in European
countries [17]
Air exchange rate Ventilation rate per occupant
Country Mean Median One-GSD Mean Median One-GSD
rangea rangea
h−1 h−1 h−1 lps pp lps pp lps pp
Austria 0.9 0.7 (0.4-1.3) 25 21 (11.1-39.1)
Belgium 0.7 0.6 (0.3-1.1) 17 14 (7.6-26.7)
Bulgaria 0.7 0.6 (0.3-1.1) 15 12 (6.4-22.3)
Cyprus 1.2 1.0 (0.5-1.9) 24 20 (10.6-37.2)
Czech Republic 0.6 0.5 (0.3-1.0) 14 11 (6.0-21.1)
Denmark 0.7 0.5 (0.3-1.0) 24 20 (10.4-36.6)
Estonia 0.7 0.5 (0.3-1.0) 13 10 (5.5-19.4)
Finland 0.7 0.5 (0.3-1.0) 17 14 (7.5-26.3)
France 0.6 0.5 (0.3-1.0) 18 14 (7.7-27.1)
Germany 0.7 0.6 (0.3-1.0) 20 17 (8.8-31.0)
Greece 1.0 0.8 (0.4-1.5) 20 17 (8.8-30.9)
Hungary 0.8 0.6 (0.3-1.2) 16 13 (6.8-24.0)
Ireland 0.6 0.5 (0.3-0.9) 14 12 (6.2-21.9)
Italy 0.8 0.6 (0.3-1.2) 21 17 (9.2-32.4)
Latvia 0.7 0.5 (0.3-1.0) 11 9 (4.9-17.2)
Lithuania 0.7 0.6 (0.3-1.0) 11 9 (4.9-17.3)
Luxembourg 0.9 0.7 (0.4-1.3) 32 26 (14.1-49.5)
Netherlands 0.7 0.6 (0.3-1.0) 21 17 (9.1-32.1)
Poland 0.7 0.6 (0.3-1.1) 11 9 (4.8-16.7)
Portugal 0.7 0.6 (0.3-1.1) 15 12 (6.6-23.1)
Romania 0.8 0.6 (0.3-1.2) 7 6 (3.2-11.1)
Slovakia 0.8 0.6 (0.3-1.2) 12 10 (5.1-17.9)
Slovenia 0.7 0.6 (0.3-1.1) 13 11 (5.9-20.7)
Spain 0.8 0.7 (0.3-1.2) 20 17 (8.9-31.3)
Sweden 0.6 0.5 (0.3-1.0) 20 17 (9.0-31.5)
UK 0.6 0.5 (0.3-0.9) 15 13 (6.8-23.8)
EU-26 0.7 0.6 (0.3-1.1) 17 14 (7.3-25.6)
a(median/GSD, median x GSD), GSD = Geometric Standard Deviation
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estimates were produced by using national level BoD data
and scaling the attributable fraction according to the ratio
of national versus European indoor concentration esti-
mates of each pollutant (i.e. PM2.5, outdoor bioaerosols,
VOC, carbon oxide (CO) radon and dampness). Popula-
tion weighted European average was used in cases where
national level data was not available.
In the current work second hand smoke exposures at
home were added to the list of pollutants using exposure
data from a European survey [23]. In addition, the earlier
PM2.5, radon and dampness models were updated to the
relative risk-based population attributable fraction (PAF)
as [24]:
PAF ¼ f  RR−1ð Þ
f  RR−1ð Þ þ 1 ð4Þ
where f is the fraction of population exposed to a given
factor and RR is the relative risk of the exposed popula-
tion. WHO estimates for national burden of disease in
2004 were used for the background BoD [25] (see sup-
porting information, Additional file 1: Table S1) to cal-
culate the environmental burden of disease (EBD)
caused by the current exposures (Table 2)
EBD ¼ PAF  BoD ð5Þ
The relative risk at the current exposure level (E)
was estimated from epidemiological relative risk (RR°)
expressed per a standard exposure increment:
RR ¼ e E lnRRð Þ ¼ RRE ð6Þ
Pollutant specific diseases and methodology are pre-
sented in Table 3. PAFs for each country and pollutant can
be found from supporting information Additional file 2:
Table S2.
Exposure control scenarios
The mass-balance enhanced burden of disease model
was used to evaluate the ability of three alternative ex-
posure control scenarios to reduce BoD. In the first sce-
nario the ventilation level was optimised by finding the
ventilation rate with lowest health effects (i.e. solving the
health-based optimum level of ventilation). In the sec-
ond scenario optimised ventilation was combined with
adjusting the filtration level to control outdoor pollut-
ants entering indoors. In the third scenario indoor
sources were controlled with ventilation set to the level
of minimum requirements.
Scenario 1: Dilution with health-based optimum level
ventilation
In the first exposure reduction scenario, indoor and out-
door sources were kept unchanged and only ventilation
rate was adjusted to find the health-based optimum level
of ventilation. In this scenario, increased level of ventila-
tion decreases the pollutant concentrations from indoor
sources and increases contribution of outdoor sources
indoors. The health-based optimum level of ventilation
was solved for each country among EU-26 by calculating
the burden of disease with ventilation rates from 0.1 to
50 lps pp.
Use of mass-balance dilution model is based on as-
sumption that all indoor originating sources follow a
constant rate of emissions even though this is not self-
evident for several indoor originating pollutants, in this
case especially for radon and dampness. In some ventila-
tion systems higher ventilation rates may cause under
pressure indoors and this may increase infiltration of
radon from the soil below the buildings. In addition, in
cases where dampness is created by condensation, higher
ventilation rates may increase the problem. However, the
benefits of higher ventilation rates were calculated as-
suming the mass-balance for a constant source term for
these pollutants too.
Scenario 2: Filtration of intake air
Analyses of scenario 1 showed that in cases where out-
door air is polluted, it may become a significant source
of exposures indoors. Therefore, in the second scenario
the burden of disease was attempted to reduce by con-
trolling the penetration of pollutants from outdoors to
indoors with increased filtration. Filtration efficiency was
specified for PM2.5 particles.
Three levels of filtration were compared. In the
baseline scenario it was assumed that 90 % of the
outdoor PM2.5 mass concentration penetrates indoors.
In addition, realistic but increasingly challenging
penetration levels of 70 % and 50 % were evaluated.
These correspond to effective filtration of PM2.5 mass
concentration by 27 % and 45 %, respectively, and
these kind of filtration levels can be achieved in real
buildings at least when using mechanical ventilation
systems [13]. When discussing the filtration efficien-
cies of filters and the above mentioned penetration
efficiencies, it has to be noted that the penetration ef-
ficiency is defined for the building, accounting for
leaks and ventilation from windows, doors etc.
The ventilation rate in this scenario was set to a health-
based optimum ventilation (i.e. ventilation level with the
lowest health effects) defined separately for each filtration
level. Burden of disease was then calculated with these
ventilation levels and compared to the BoD in the baseline
scenario to estimate the achievable health benefits.
Scenario 3: Source control and minimum ventilation (4 lps pp)
In the third scenario the exposures of the indoor sources
were assumed to be reduced with the following emission
control potentials for the considered pollutants:
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 -90 % for radon, carbon monoxide (CO) and second
hand smoke (SHS)
 -50 % for volatile organic compounds (VOC) and
dampness
 -25 % for particulate matter (PM2.5)
These control potentials were defined as hypothetical,
technically feasible maximum reductions evaluated by
the authors. The radon estimate assumes highly efficient
application and control of radon safe construction in
radon-prone areas combined with control of second
hand smoke exposures known to act synergistically with
radon. Efficient second hand smoke reductions have
already been demonstrated in Finland in both work-
places and in homes resulting a decrease in proportion
of adolescents exposed to SHS from 17 % in 1991 to 6 %
in 2009 [26] and the SHS policies are moving forward also
on at European level. The carbon monoxide exposures
were assumed to be reduced by compulsory alarms that
will notify residents when carbon monoxide levels are in-
creasing because of malfunctioning devices or fires.
VOC levels are assumed to be controlled by new low
emitting products and wider use of comprehensive label-
ling systems for low emission products. Dampness
Table 2 Outdoor and indoor exposure levels (PM2.5, radon and VOC) and prevalence of exposure (dampness in homes and second
hand smoke of non-smoking population) in European countries used for burden of disease calculations
a)Out. PM2.5
b)Ind. PM2.5
c)Out. VOC d)Ind. VOC e)Ind. Radon f)Dampness homes g)SHS non-smokers
μg m−3 μg m−3 μg m−3 μg m−3 Bq m−3 % %
Austria 17 5 103 298 97 8 14
Belgium 19 5 103 298 69 14 18
Bulgaria 22 5 103 298 30 n/a 23
Cyprus 23 4 103 298 7 30 31
Czech Republic 23 5 116 334 (8 140 16 16
Denmark 13 3 103 298 53 11 17
Estonia 11 3 103 298 120 23 16
Finland 9 3 64 226 (8 120 5 2
France 12 5 77 223 (9 89 14 9
Germany 16 5 103 297 (10 50 13 13
Greece 21 4 155 345 (9 55 19 28
Hungary 25 5 103 298 107 19 12
Ireland 8 3 103 298 89 15 14
Italy 20 4 181 489 (8 70 21 11
Latvia 12 3 103 298 n/a 26 12
Lithuania 14 3 103 298 55 25 28
Luxembourg 12 5 52 148 (9 115 15 8
Netherlands 19 5 46 134 (9 30 18 15
Poland 22 5 103 298 49 37 21
Portugal 18 4 38 213 (9 86 20 13
Romania 23 5 103 298 45 29 23
Slovakia 23 5 103 298 87 6 13
Slovenia 17 5 103 298 87 17 14
Spain 16 4 103 298 90 18 20
Sweden 10 3 77 223 (11 108 6 3
UK 13 3 85 245 (8 20 15 7
EU-26 17 4 104 298 64 18 14
a)De Leeuw and Horalek, 2009 [28], b)Hänninen, et al. 2004 [11] (in case of missing data, European average value used), c)Outdoor VOC concentrations were
calculated based on indoor concentrations by using data on fraction estimations from literature (Finland 0,22, Greece 0.31, Italy 0.27, Portugal 0.15, other countries
0.26 (population weighted EU-26 mean value based on the four previous values), d)Data on indoor VOC concentrations collected from several source (indicated
separately, in case of missing data, European average value used, indicated with italics), e)EU Radonmapping [29] (in case of missing data, European average value
used), f)WHO/ENHIS Fact Sheet 3.5 [30], g)Survey on Tobacco, Eurobarometer 253, 2009 [23], h)EXPOLIS study Jantunen MJ. et al. 1998 [31], i)IAIAQ model, Jantunen
et al. 2012 [22], j)GerEs study: http://www.umweltbundesamt.de/en/topics/health/assessing-environmentally-related-health-risks/german-environmental-survey-geres,
k)Norback, D. et al. 1995 [32].
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controls need to combine better constructions practises
and structural improvements with active/online and pas-
sive warning sensors. However, the greatest challenge is
to control particulate matter. The proposed 25 % reduc-
tion is assumed to be achieved with target exhausts in
kitchens, avoiding use of candles and improved design of
combustion devices.
To provide some sensitivity analysis to estimate the ef-
fectiveness of source control, two other scenarios with
lower and higher source control capabilities were also
analysed. In the lower source control scenario (scenario
3.1), it was assumed a reduction of 80 % for radon, CO
and SHS and 25 % reduction of PM2.5, VOC and damp-
ness exposures. In the higher source control scenario
(scenario 3.2), a total control (100 %) of radon, CO and
SHS and 75 % reduction of PM2.5, VOC and dampness
exposures were assumed.
In all source control scenarios, the ventilation level
was set to be 4 lps pp, which was proposed as base ven-
tilation rate in cases when ventilation must handle only
human bio-effluent emissions (carbon dioxide (CO2) and
moisture) by work done in HealthVent (report will be
published separately). In presence of any other indoor
sources, level of ventilation needs to be adjusted to ac-
ceptable level.
Results
Burden of disease caused by indoor exposures in 2010
An annual loss of 2.1 million DALYs in EU-26 is associ-
ated to indoor and outdoor originating pollutants with
more than half of it (1.28 million DALYs) caused by
exposures to outdoor air pollution indoors and the
remaining 0.74 million DALYs caused by indoor
source pollutants.
This burden of disease is dominated by cardiovascular
(CV) diseases as a result of exposure to outdoor and in-
door particles and second hand smoke, corresponding
57 % of the total burden of disease (Fig. 1). The second
largest contribution comes from lung cancer (23 %) and
the third in the list is asthma (total of 12 %). The
remaining 8 % is divided between various respiratory
symptoms and conditions.
The total burden of disease for individual countries
varies considerably with the highest burden of 10 000
DALY per one million population in Bulgaria to the low-
est one of 2 000 DALY per million in Sweden. The EU-
26 average burden of disease is slightly over 4 000 DALY
in a year per one million population. The higher levels
in East-European countries are dominated by high con-
tribution of outdoor sources, which vary from 46 %
(Ireland) to 75 % (Bulgaria) (Fig. 2).
Source contributions to burden of disease
Overall in EU-26, almost 80 % of the total annual bur-
den of disease of indoor exposures (i.e. 4 000 DALYs/
million) is estimated to be caused by PM2.5, dominated
by particulates originating from outdoor air penetrating
indoors (Fig. 3).
Comparison of the sources of burden of disease in
Finland (Fig. 3) and in other EU-26 countries (Table 4)
shows clear differences between countries. As an ex-
ample, in Finland the role of ambient particles is lower
than on average in the EU-26 countries, but both bio-
aerosols (pollen) and radon play much more significant
Table 3 Diseases and exposure-response relationships included in this assessment
Exposuresa Health endpoints WHO RR PAF RR & PAF source(s) BoD calculationb
PM2.5 Asthma W113 1.009 f(RR, E)
c Pope et al. 2002 [33] PAF(E, RR) × BoD2004
Lung cancer W067 1.014 f(RR, E)c Pope et al. 2002 [33] PAF(E, RR) × BoD2004
CV-diseases W104 1.009 f(RR, E)c Pope et al. 2002 [33] PAF(E, RR) × BoD2004
COPD W112 1.009 f(RR, E)c Pope et al. 2002 [33] PAF(E, RR) × BoD2004
Outdoor bioaerosols Asthma W113 n/a 0.1d Jantunen et al., 2010 [22] PAF × BoD2004
VOC Asthma W113 n/a 0.05e Jantunen et al., 2010 [22] C/CEU × PAF × BoD2004
CO Acute toxication caused by carbon monoxide n/a n/a 0.9e Jantunen et al., 2010 [22] Cases x 20 years lost/case
Radon Lung cancer W067 1.0014 f(RR, E)c Darby et al., 2005 [34] PAF(E, RR) × BoD2004
Home dampness Respiratory infections W038 1.37 f(RR, E)c Fisk et al., 2007 [35] PAF(E, RR) × BoD2004
Asthma W113 1.5 f(RR, E)c Fisk et al., 2007 [35] PAF(E, RR) × BoD2004
SHSf Lung cancer W067 1.21 f(RR, E)c US S.G. 2006 [36] PAF(E, RR) × BoD2004
Ischaemic heart disease W107 1.27 f(RR, E)c US S.G. 2006 [36] PAF(E, RR) × BoD2004
Asthma W113 1.97 f(RR, E)c Jaakkola et al., 2003 [37] PAF(E, RR) × BoD2004
a)Population weighted average in EU26, b)C = National population weighted concentration, CEU = European average concentration, E = National population
weighted exposure, c)Calculated as PAF = (f × (RR-1))/((f × (RR-1)) + 1), where RR = RR°E (see equation 4) [24], d)Original value of 0.25 in Jantunen et al. (2010) [22]
adjusted to 0.1 due to separation of indoor and outdoor sources and focusing on pollen from outdoor air, e)Expert judgment PAF from the EnVIE panel used
directly [21], see column PAF,
f)Second hand smoke exposure of non-smoking adults at home.
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roles, the latter contributing double to that than for the
European average.
Even though dampness and mould problems continu-
ously raise a lot of attention in Finland, only 3 % of the
total BoD is estimated to be caused by dampness being
at the lower end on the European scale (ranging from
1 % to 11 %),
Health benefits of exposure control scenarios
Each of the described three exposure control scenarios
provides health benefits compared to the 2010 baseline
scenario in EU-26 so, that 20 % reduction of burden of
disease was achieved with the dilution scenario, 38 % re-
duction with the filtration scenario, and 44 % reduction
with the indoor source control scenario (changing from
41 % to 54 % depending on assumed source reductions)
(Fig. 4).
In the dilution-based scenario 1, reduction of indoor
originating exposures with increased ventilation is com-
pensated by increased penetration of outdoor pollution
leading to a lower health benefits. In this scenario, the
lowest burden of disease in EU-26 is found at mean ven-
tilation level of 4.4 lps pp, which is clearly lower than
the mean ventilation in the existing building stock (17
Fig. 2 Total burden of disease as DALY/million population from indoor exposures in EU-26 countries with division to indoor and outdoor sources
in the 2010 building stock (reproduced from Asikainen & Hänninen [20])
Fig. 1 Attributable burden of diseases due to indoor exposures in 2010 in EU-26. The lighter shade of blue and red represents the maximum
fraction that can be reduced by actions (scenarios) presented in this paper (reproduced from Asikainen & Hänninen [20])
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lps pp) defined by the regression modelled probability
distributions (Table 1) [17, 20].
Approximately twice as high benefits are achievable by
filtration of outdoor air in scenario 2. The results for max-
imum feasible filtration (with penetration fraction P = 50 %)
show that 38 % reduction in burden of disease (800 000
DALYs) in EU-26 can be achieved. The European optimum
mean ventilation level with lowest burden of disease is then
7.7 lps pp. This scenario would in practice imply substantial
change towards mechanical ventilation systems in Europe.
In the Nordic countries, this is already the practice due to
the energy efficiency norms, but, in the majority of
the European building stock, the filtration scenario
would require a substantial step towards installing
mechanical systems.
The largest health benefits can be achieved by the
source control approach (scenario 3.0), which signifi-
cantly reduces the need to control exposures by dilution.
The benefits are approximately 44 % from the baseline
(940 000 DALYs) in EU-26, and changing from
reduction of 41 % (865 000 DALYs) with lower source
control assumptions in scenario 3.1to 57 % (1.21 million
DALY) with higher source control assumptions in sce-
nario 3.2, demonstrating source control to be more ef-
fective than dilution or filtration even with smaller
reductions of source exposures.
In addition to higher health benefits and compared to
the filtration-based scenario 2, the advantage of the
source control scenario 3 is that lower dilution need
(i.e. enabling lower ventilation rate) allows also for
lower infiltration of outdoor particles and therefore the
feasibility of approach is better in the current building
stock. Moreover, requiring lower ventilation rates the
source control approach is likely to prove also more
energy-efficient.
Further analysis of the contribution of indoor and out-
door sources shows, that with the dilution scenario 1 the
health benefits are not only due to smaller proportion of
the indoor contribution (i.e. the dilution of the pollut-
ants from the indoor sources), but is mainly due to the
Fig. 3 Burden of disease attributable to indoor exposures in EU-26 (2.1 M DALY/a) and in Finland (13 k DALY/a) in 2010 divided into source
contributions (reproduced from Asikainen & Hänninen [20])
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Table 4 Contribution (%) of different sources to the total DALYs in 2010
Country Ind. PM2.5 Radon Ind. VOC CO Damp. SHS Out. PM2.5 Bio-aerosols Out. VOC
Austria 18 11 1 1 1 5 58 3 0
Belgium 18 9 1 0 4 4 60 3 0
Bulgaria 17 2 0 0 3 2 74 1 0
Cyprus 11 0 1 0 11 12 61 3 0
Czech Republic 14 12 1 4 3 3 61 2 0
Denmark 13 9 2 3 3 6 59 5 1
Estonia 14 13 1 5 8 4 52 3 0
Finland 16 16 2 4 3 2 50 7 1
France 20 18 2 0 5 2 46 6 1
Germany 20 6 1 1 3 4 60 3 0
Greece 14 6 1 1 4 5 68 2 0
Hungary 15 12 0 1 1 1 69 1 0
Ireland 13 12 4 2 11 12 34 11 1
Italy 14 9 2 1 4 3 64 3 1
Latvia 15 6 1 2 7 3 64 2 0
Lithuania 14 5 0 0 6 10 63 1 0
Luxembourg 21 15 1 1 6 3 47 5 0
Netherlands 18 4 1 1 6 5 61 5 0
Poland 15 5 1 1 6 3 66 2 0
Portugal 14 7 1 1 7 4 62 4 0
Romania 16 3 0 1 7 2 70 1 0
Slovakia 16 7 1 1 2 3 70 2 0
Slovenia 17 11 1 2 5 3 56 3 0
Spain 14 14 1 0 5 4 57 4 0
Sweden 16 15 2 2 3 3 54 6 1
United 13 3 2 1 8 5 59 8 1
EU-26 16 8 1 1 5 4 62 3 0
Fig. 4 Burden of disease at the baseline (2010) in comparison with alternative potential control strategies in EU-26 (in millions of DALYs) (reproduced
from Asikainen & Hänninen [20])
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lower ventilation rates that limit the penetration of the
outdoor pollutants indoors.
In the filtration scenario 2 the health benefits are due
to filtration of the outdoor pollutants and also effective
dilution of the indoor pollutants, as the health-based op-
timal ventilation levels are higher.
Furthermore, in the source control scenarios, the
health benefits are a result of both effects: lower indoor
sources due to the source control and lower penetration
of outdoor pollutants due to low level of ventilation.
Discussion
The results suggest that (i) there is a substantial burden
of disease associated with exposures taking place indoors
and that (ii) these risks can substantially be reduced
by range of control actions affecting indoor pollution
sources, infiltration of outdoor pollutants, and venti-
lation levels. Besides the estimated health benefits
and policy implementation costs, the suggested
prioritization of the policies depends also on the un-
certainties of the estimates.
Substantial uncertainty is raised by model uncertainties,
including the selection of pollutants to be considered as
relevant for indoor exposures and the health end-points
associated with them. It is not clear how much the burden
of disease estimates are underestimated due to the dozens
of ignored exposures or missing health endpoints for the
included exposures. The model uncertainties could and
should be qualitatively evaluated by experts before the im-
plementation of results.
The other aspect of the model uncertainties is related
on model parameters. Variable degree of uncertainty ex-
ists in the exposure-response response relationships
based on epidemiological studies. For some of the in-
cluded pollutants, such as PM2.5 originating from out-
door air, this data is based on a large number of studies,
representing very large populations in different climato-
logical regions. In this study, the exposure-response rela-
tionship of ambient particles has also been used for
indoor generated particles. The indoor generated parti-
cles have partly similar composition, originating from
combustion processes or being re-suspended particles
originating from soil, thus it is reasonable to assume
similar toxicity as for the ambient particles. However,
some particle fractions, especially the particles generated
from food cooking, from the skin and clothes of occu-
pants, and from interior textiles, have a different chem-
ical composition with limited direct evidence on their
toxicity. This may lead on overestimation of the health
effects caused by indoor PM2.5. Significance of this varies
between the countries, since portion of health effects
caused by indoor PM2.5 from the total burden of disease
on baseline 2010 changes from 13 % to 21 %
(Table 4). Average contribution of indoor PM2.5 in
EU-26 is 16 % (Fig. 3), so this fraction could be re-
moved from total BoD, if considered too uncertain
due to the lack of toxicological evidence. In this case,
the contribution of indoor sources would decrease in
all scenarios and outdoor component would become
the dominant one, also in the scenario 2 and in the
scenario 3. However, the overall performance and
order of scenarios would not change, so the conclu-
sions would remain the same.
Scenarios including projections to future rely always
on assumed changes in the investigated environments
and factors, and we may not know all changes that need
to be accounted for. Also the implementation timeframe
of selected actions or policies need to be considered. In
this case the most significant element in the scenario
uncertainties is related to the development of future
building stocks [27]. This includes also changes in the
technical solutions of ventilation systems, which are not
specifically defined in the current ventilation guidelines.
An example of this is the filtration of outdoor air pollu-
tion, especially PM2.5, but also pollen, other biological
particles, ozone, ultrafine traffic particles and so on. In-
filtration of ambient particles depends on air exchange
rates, size distribution of the outdoor particles, and fil-
tration of the intake air. At lower air exchange rates the
prolonged residence time of air indoors and correspond-
ing deposition of the larger particles on indoor surfaces
reduces indoor exposures even when the outdoor air is
not filtrated. Using window frames and other sedimenta-
tion chambers allows for filtrating particles even in nat-
ural ventilation systems. Nevertheless, active filtration
becomes efficient only in mechanical systems using high
quality (above FP7) filters.
The used ventilation rate estimates per occupant (lps
pp) are calculated using average residence sizes and
average numbers of occupants in each country. Popula-
tion weighted average outdoor concentrations have also
been used to estimate the indoor exposures. It is clear
that the air filtration needs for a specific building have
to be defined taken into account the ambient air quality
at the selected building location. In all countries consid-
ered, there are locations where the outdoor levels exceed
the WHO guidelines much more than the national av-
erages used here indicate. When the current methods
are proposed to determine the potential filtration
needs, they have to be applied with worst case esti-
mates for the actual building site, accounting for the
whole service life cycle.
Largest health benefits were projected for the source
control policies. It is obvious that the benefits are
achievable only if the source controls work as efficiently
as proposed and that the efficiency of the source con-
trols must be confirmed with follow-up (e.g. auditing) of
exposure levels after the policy enforcement.
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Conclusions
Over 2 million disability adjusted life years (DALY)
are annually lost in the European Union due to com-
promised indoor air quality, but this burden of dis-
ease can be reduced by adjusting ventilation,
filtration of intake air and by controlling indoor
sources. All three approaches are able to provide
substantial reductions in the health risks from ap-
proximately 20 % to almost 50 %, corresponding to
400 000 and 900 000 saved DALYs in EU-26. Thus
selection of strategies has substantial impact on the
expected benefits.
The projected health benefits can be achieved if the
controls on ventilation and sources are fully imple-
mented as defined in the scenario descriptions. In the
case of selecting some of the proposed strategies for im-
plementation, a careful follow-up plan has to be devel-
oped for ensuring that the controls are effective and
match the requirements of the benefit calculations.
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